Your browser doesn't support javascript.
loading
Baseline lymphocyte and cholinesterase levels may be the predictors of chronic herbal drug-induced liver injury.
Zeng, Zhan; Yi, Wei; Dong, Jian-Ping; Chen, Qi-Qi; Sun, Fang-Fang; Lu, Hui-Hui; Lin, Yan-Jie; Bi, Xiao-Yue; Yang, Liu; Lu, Yao; Zhang, Lu; Li, Ming-Hui; Xie, Yao.
Afiliação
  • Zeng Z; Department of Hepatology Division 2, Peking University Ditan Teaching Hospital, Beijing, China.
  • Yi W; Department of Gynecology and Obstetrics, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Dong JP; Department of Infectious Diseases, Haidian Hospital, Beijing Haidian Section of Peking University Third Hospital, Beijing, China.
  • Chen QQ; Department of Hepatology Division 2, Peking University Ditan Teaching Hospital, Beijing, China.
  • Sun FF; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Lu HH; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Lin YJ; Department of Hepatology Division 2, Peking University Ditan Teaching Hospital, Beijing, China.
  • Bi XY; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Yang L; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Lu Y; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Zhang L; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Li MH; Department of Hepatology Division 2, Peking University Ditan Teaching Hospital, Beijing, China.
  • Xie Y; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Front Pharmacol ; 13: 962480, 2022.
Article em En | MEDLINE | ID: mdl-35991883
Objective: To investigate the factors influencing the chronicity of drug-induced liver injury (DILI) caused by Chinese herbal medicine. Methods: Patients with DILI diagnosed by using the RUCAM score were enrolled retrospectively. The subjects were patients with DILI induced by taking Chinese herbal medicine and were followed up for 48 weeks. These patients were divided into a cure group and a chronic group. The biochemical indicators were monitored at baseline and every 3 months. Logistic regression was used to analyze the risk factors of DILI chronicity. The ROC (receiver operator characteristic) curve was used to analyze the diagnostic efficiency of each factor. Results: A total of 420 patients with DILI were enrolled; 122 of them were caused by Chinese herbal medicine, 70.5% (86/122) of them were female, chronic group 31.2% (39/122), and cure group 68.0% (83/122); cholinesterase (ChE) in the chronic group was lower than that in the cure group (5467.10 ± 2010.40 U/L vs. 6248.52 ± 1901.78 U/L, p = 0.04, t = 2.078). There was no significant difference in the age between cured patients and chronic patients (p = 0.156, Z = -1.417). There was no significant difference between the prognosis of different genders (p = 0.521, Z = -0.639). The logistic regression analysis showed that baseline lymphocyte (OR = 0.429, 95%CI = 0.205-0.898, p = 0.025) and cholinesterase (OR = 0.088, 95%CI = 0.008-0.994, p = 0.049) were independent risk factors of drug-induced chronicity. Conclusion: Baseline lymphocyte and cholinesterase may be the predictive factors for the chronicity of Chinese herbal medicine-induced liver injury.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China